These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 18586683)
41. A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Murray PT; Reddy BV; Grossman EJ; Hammes MS; Trevino S; Ferrell J; Tang I; Hursting MJ; Shamp TR; Swan SK Kidney Int; 2004 Dec; 66(6):2446-53. PubMed ID: 15569338 [TBL] [Abstract][Full Text] [Related]
42. Thrombin generation test in patients under anticoagulant therapy with vitamin K antagonists. Brocal I; Marco P; Lucas J; Verdú J; Tarín F Thromb Haemost; 2009 Mar; 101(3):594-5. PubMed ID: 19277428 [No Abstract] [Full Text] [Related]
43. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions. Mani H; Hesse C; Stratmann G; Lindhoff-Last E Thromb Haemost; 2013 Jan; 109(1):127-36. PubMed ID: 23138190 [TBL] [Abstract][Full Text] [Related]
44. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin. Li N; He S; Blombäck M; Hjemdahl P Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):407-13. PubMed ID: 17138937 [TBL] [Abstract][Full Text] [Related]
45. Variability of INR in patients on stable long-term treatment with phenprocoumon and acenocoumarol and implications for analytical quality requirements. van Geest-Daalderop JH; Péquériaux NC; van den Besselaar AM Thromb Haemost; 2009 Sep; 102(3):588-92. PubMed ID: 19718481 [TBL] [Abstract][Full Text] [Related]
46. In vitro effects of a kaolin-coated hemostatic dressing on anticoagulated blood. Cripps MW; Cornelius CC; Nakonezny PA; Vazquez N; Wey JC; Gales PE J Trauma Acute Care Surg; 2018 Sep; 85(3):485-490. PubMed ID: 29851903 [TBL] [Abstract][Full Text] [Related]
47. Effect of low-dose supplements of menaquinone-7 (vitamin K2 ) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers. Theuwissen E; Teunissen KJ; Spronk HM; Hamulyák K; Ten Cate H; Shearer MJ; Vermeer C; Schurgers LJ J Thromb Haemost; 2013 Jun; 11(6):1085-92. PubMed ID: 23530987 [TBL] [Abstract][Full Text] [Related]
48. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans. Hollenstein U; Homoncik M; Knöbl P; Pernerstorfer T; Graggaber J; Eichler HG; Handler S; Jilma B Clin Pharmacol Ther; 2002 May; 71(5):368-74. PubMed ID: 12011822 [TBL] [Abstract][Full Text] [Related]
49. Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy. Khorsand N; Veeger NJ; Muller M; Overdiek JW; Huisman W; van Hest RM; Meijer K Transfus Med; 2011 Apr; 21(2):116-23. PubMed ID: 21073580 [TBL] [Abstract][Full Text] [Related]
50. Effectiveness of vitamin K in anticoagulation reversal for hip fracture surgery--a prospective observational study. Buecking B; Eschbach D; Bliemel C; Oberkircher L; Struewer J; Ruchholtz S; Sachs UJ Thromb Res; 2014 Jan; 133(1):42-7. PubMed ID: 24196230 [TBL] [Abstract][Full Text] [Related]
51. Subtherapeutic oral anticoagulant therapy: frequency and risk factors. Rombouts EK; Rosendaal FR; van der Meer FJ Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419 [TBL] [Abstract][Full Text] [Related]
52. Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. Lorenz R; Kienast J; Otto U; Kiehl M; Schreiter D; Haertel S; Barthels M Blood Coagul Fibrinolysis; 2007 Sep; 18(6):565-70. PubMed ID: 17762533 [TBL] [Abstract][Full Text] [Related]
53. Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs. Hoppensteadt DA; Kahn S; Fareed J Clin Chem; 1997 Sep; 43(9):1786-8. PubMed ID: 9299979 [No Abstract] [Full Text] [Related]
54. [Switching from acenocoumarol to phenprocoumon: step in personalised anticoagulation?]. van Miert JHA; Piersma-Wichers M; Meijer K Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34523845 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses. van Schie RM; Aoussar A; van der Meer FJ; de Boer A; Maitland-van der Zee AH J Thromb Haemost; 2013 Jun; 11(6):1200-3. PubMed ID: 23510058 [No Abstract] [Full Text] [Related]
56. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio. Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631 [TBL] [Abstract][Full Text] [Related]
57. Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin. Veeger NJ; Zijlstra F; Hillege HL; van der Meer J; Ann Thorac Surg; 2010 Nov; 90(5):1515-21. PubMed ID: 20971252 [TBL] [Abstract][Full Text] [Related]
58. Life threatening bleeding under adequate oral anticoagulation. Cases 4a, b. Aegerter Ch; Fontana S; Fux Ch; Demarmels Biasiutti F Hamostaseologie; 2003 Aug; 23(3):113-6. PubMed ID: 12923579 [TBL] [Abstract][Full Text] [Related]
59. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays. Choi Q; Kim JE; Hyun J; Han KS; Kim HK Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659 [TBL] [Abstract][Full Text] [Related]
60. The effect of vitamin K supplementation on anticoagulant treatment. Rombouts EK; Rosendaal FR; van der Meer FJ J Thromb Haemost; 2006 Mar; 4(3):691-2. PubMed ID: 16460460 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]